Pooria Safarzadeh Kozani

9PUBLICATIONS
11CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Autonomic nervous systemGene and molecular therapyMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 15, 2026
EF-1α-driven nanobody-based CD19-redirected CAR-T cells retain the antitumor efficacy, antigen-driven expansion, and cytokine secretion of CMV-driven counterparts.

|Feb 19, 2026
CAR-T cell immunotherapy in rhabdomyosarcoma.

Pooria Safarzadeh Kozani, Setareh Dashti Shokoohi, Pouya Safarzadeh Kozani

|Oct 22, 2025
Preventing secondary primary malignancies (SPMs) in CAR-T cell therapy through site-specific transgene integration into genomic safe harbors (GSHs).

Pooria Safarzadeh Kozani, Pouya Safarzadeh Kozani

|Jul 24, 2025
Characterization of a Phage Display-Selected scFv Against Neuropilin 1 (NRP1) Isolated from a Naïve Human Library.

Khadijeh Farrokhi, Fatemeh Nasiri, Pouya Safarzadeh Kozani

|Feb 26, 2025
Novel sACE2-Anti-CD16VHH Fusion Protein Surreptitiously Inhibits SARS-CoV-2 Variant Spike Proteins and Macrophage Cytokines, and Activates Natural Killer Cell Cytotoxicity.

Abdolkarim Sheikhi, Leili Baghaie, Fatemeh Rahbarizadeh

|Apr 26, 2022
Nanobody-based CAR-T cells for cancer immunotherapy.

Pouya Safarzadeh Kozani, Abdolhossein Naseri, Seyed Mohamad Javad Mirarefin

Pageof 2

Frequent Collaborators

5 joint publications

Pouya Safarzadeh Kozani

2 joint publications

Fatemeh Rahbarizadeh

1 joint publications

Abdolkarim Sheikhi

1 joint publications

Leili Baghaie